Resources - Scientific Posters

A Simple, Robust Automated Multiplexed Cell-Based Assay Process for the Assessment of Mitochondrial Dysfunction and Cytotoxicity

Download

Related Products: Precision

February 08, 2012

 

Authors: Brad Larson, Peter Banks, BioTek Instruments, Inc; Tracy Worzella, Andrew Niles, Promega Corporation; Timothy Moeller, Celsis In Vitro Technologies

 

Promega logo      Celsis
 

The primary function of mitochondria is to generate >90% of a cell’s energy in the form of ATP, through the process of oxidative phosphorylation. The impairment of this function can lead to negative effects on tissues such as reduced cellular function or cellular death. Recent studies have shown that an increasing number of drugs no longer on the market have negative effects on mitochondrial function in key organs such as the liver and heart. Therefore it is increasingly important to monitor the effects of lead compounds on mitochondrial function in relevant cell systems. The ability to incorporate a simple, rapid, multiplexed, predictive assay can make the detection of potential toxic effects easier to perform early on in the drug discovery process. Here we demonstrate the automation and validation of such an assay in a highdensity well format, using HepG2 and primary hepatocyte cell models.

    

link